Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|April 26, 2020
Monovalent protein-degraders - Insights and future perspectivesIvan Cornella-Taracido, Carlos Garcia-EcheverriaJournal of Medicinal Chemistry|August 19, 2017
Causes and Significance of Increased Compound Potency in Cellular or Physiological ContextsAdam G Schwaid, Ivan Cornella-TaracidoScientific Reports|September 9, 2018
Comparison of the Rat and Human Dorsal Root Ganglion ProteomeAdam G Schwaid, Alicja Krasowka-Zoladek, An Chi, et al.ACS Medicinal Chemistry Letters|August 20, 2021
Rapid Evaluation of Small Molecule Cellular Target Engagement with a Luminescent Thermal Shift AssayJonathan D Mortison, Ivan Cornella-Taracido, Gireedhar Venkatchalam, et al.Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Kinase inhibitor profiling using chemoproteomicsMarkus Schirle, Eugene C Petrella, Scott M Brittain, et al.Cell Chemical Biology|November 10, 2022
Chemoproteomic profiling to identify activity changes and functional inhibitors of DNA-binding proteinsBenjamin Ruprecht, Lan Wei, Li Zheng, et al.ACS Chemical Biology|October 28, 2015
Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase ActivityCarrie M Gower, Jason R Thomas, Edmund Harrington, et al.Journal of Proteome Research|March 11, 2009
Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography dataAndreas Bender, Dmitri Mikhailov, Meir Glick, et al.JCI Insight|January 12, 2018
Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicityAarti Asnani, Baohui Zheng, Yan Liu, et al.Blood|April 14, 2011
Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cellsCarla Russo, Ivan Cornella-Taracido, Luisa Galli-Stampino, et al.Pageof 2